Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic alterations in tp53 in recurrent urothelial cancer: a longitudinal study.

Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Sept 2001

Dalbagni G, Ren Z P, Herr H, Cordon-Cardo C, Reuter V

Abstract excerpt

PURPOSE: Because bladder cancer has a recurrence rate that can be as high as 90% at 2 years, we sought to clarify whether these metachronous tumors are polyclonal or monoclonal in origin. We have examined the genetic alterations of the TP53 gene in a cohort of patients with urothelial cancer who underwent multiple biopsies at different times and sites because of tumor recurrence and/or progression. We postulated...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to DNA, Neoplasm
Share to Exons
Share to Longitudinal Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasm Recurrence, Local

Share to Polymorphism, Single-Stranded Conformational

Share to Tumor Suppressor Protein p53

Share to Urinary Bladder Neoplasms

Share to Urothelium

Source

Identifiers

PMID: 11555595

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic alterations in tp53 in recurrent urothelial cancer: a longitudinal study.PMID 11555595Read ↗

Genetic analysis of Tp53 from urine sediment as a tool for diagnosing recurrence and residual of bladder carcinoma.Semantic proximity Read ↗

P53 mutations as an identification marker for the clonal origin of bladder tumors and its recurrences.Semantic proximity Read ↗

Molecular Determinants of Tumor Recurrence in The Urinary BladderSemantic proximity Read ↗

Molecular screening of multifocal transitional cell carcinoma of the bladder using p53 mutations as biomarkers.Semantic proximity Read ↗

Clonality of multifocal urothelial carcinomas: 10 years of molecular genetic studiesSemantic proximity Read ↗

Analysis of genetic events in 17p13 and 9p21 regions supports predominant monoclonal origin of multifocal and recurrent bladder cancer.Semantic proximity Read ↗

Implications of p53 gene mutations on patient survival in transitional cell carcinoma of the bladder: a long-term study.Semantic proximity Read ↗

Correlation of allelic loss of the P53 gene and tumor grade, stage, and malignant progression in bladder cancer.Semantic proximity Read ↗

Recurring urothelial carcinomas show genomic rearrangements incompatible with a direct relationship.Semantic proximity Read ↗

Alteration of a p53 gene status affects outcome of patients with recurrent ovarian cancer.Semantic proximity Read ↗

p53 gene mutation in recurrent superficial bladder cancer.Semantic proximity Read ↗

TP53 gene mutations as an independent marker for urinary bladder cancer progression.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.